Form 4 for ODTX Odyssey Therapeutics, Inc.
Accepted 2026-05-11 20:32:41 ET · period of report 2026-05-08 · accession 0001193125-26-217600 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 20:32 | 2026-05-08 | ODTX | Haas Jason | CFO | P - Purchase | $20.00 | +1,000 | 62.9K | +2% | +$20.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-08 | P | A | 1,000 | $20.00 | 62,908 | D | — | — |